Impact of molecular testing in clinical practice in gynecologic cancers.
Marilyn HuangTegan HunterBrian SlomovitzMatthew P SchlumbrechtPublished in: Cancer medicine (2019)
Molecular profiling in gynecologic cancers often identified at least one actionable mutation; however, only in a minority of these cases was the course of treatment changed. Further studies are needed to elucidate optimal timing for testing to best utilize actionable information.